185 related articles for article (PubMed ID: 27734914)
1. The fecal microbiota as a biomarker for disease activity in Crohn's disease.
Tedjo DI; Smolinska A; Savelkoul PH; Masclee AA; van Schooten FJ; Pierik MJ; Penders J; Jonkers DM
Sci Rep; 2016 Oct; 6():35216. PubMed ID: 27734914
[TBL] [Abstract][Full Text] [Related]
2. Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn's Disease Patients.
Doherty MK; Ding T; Koumpouras C; Telesco SE; Monast C; Das A; Brodmerkel C; Schloss PD
mBio; 2018 Mar; 9(2):. PubMed ID: 29535202
[TBL] [Abstract][Full Text] [Related]
3. Fecal microbiota composition is linked to the postoperative disease course in patients with Crohn's disease.
Strömbeck A; Lasson A; Strid H; Sundin J; Stotzer PO; Simrén M; Magnusson MK; Öhman L
BMC Gastroenterol; 2020 May; 20(1):130. PubMed ID: 32366222
[TBL] [Abstract][Full Text] [Related]
4. Fecal microbial composition of ulcerative colitis and Crohn's disease patients in remission and subsequent exacerbation.
Wills ES; Jonkers DM; Savelkoul PH; Masclee AA; Pierik MJ; Penders J
PLoS One; 2014; 9(3):e90981. PubMed ID: 24608638
[TBL] [Abstract][Full Text] [Related]
5. Faecal Microbiota Dynamics and their Relation to Disease Course in Crohn's Disease.
Galazzo G; Tedjo DI; Wintjens DSJ; Savelkoul PHM; Masclee AAM; Bodelier AGL; Pierik MJ; Jonkers DMAE; Penders J
J Crohns Colitis; 2019 Sep; 13(10):1273-1282. PubMed ID: 30810207
[TBL] [Abstract][Full Text] [Related]
6. Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results.
Cui B; Feng Q; Wang H; Wang M; Peng Z; Li P; Huang G; Liu Z; Wu P; Fan Z; Ji G; Wang X; Wu K; Fan D; Zhang F
J Gastroenterol Hepatol; 2015 Jan; 30(1):51-8. PubMed ID: 25168749
[TBL] [Abstract][Full Text] [Related]
7. Siblings of patients with Crohn's disease exhibit a biologically relevant dysbiosis in mucosal microbial metacommunities.
Hedin C; van der Gast CJ; Rogers GB; Cuthbertson L; McCartney S; Stagg AJ; Lindsay JO; Whelan K
Gut; 2016 Jun; 65(6):944-53. PubMed ID: 25856344
[TBL] [Abstract][Full Text] [Related]
8. Volatile Organic Compounds in Exhaled Air as Novel Marker for Disease Activity in Crohn's Disease: A Metabolomic Approach.
Bodelier AG; Smolinska A; Baranska A; Dallinga JW; Mujagic Z; Vanhees K; van den Heuvel T; Masclee AA; Jonkers D; Pierik MJ; van Schooten FJ
Inflamm Bowel Dis; 2015 Aug; 21(8):1776-85. PubMed ID: 26199990
[TBL] [Abstract][Full Text] [Related]
9. Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn's disease.
Li Q; Wang C; Tang C; He Q; Li N; Li J
J Clin Gastroenterol; 2014 Jul; 48(6):513-23. PubMed ID: 24275714
[TBL] [Abstract][Full Text] [Related]
10. Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease.
Suskind DL; Brittnacher MJ; Wahbeh G; Shaffer ML; Hayden HS; Qin X; Singh N; Damman CJ; Hager KR; Nielson H; Miller SI
Inflamm Bowel Dis; 2015 Mar; 21(3):556-63. PubMed ID: 25647155
[TBL] [Abstract][Full Text] [Related]
11. Fecal microbiota transplantation inducing remission in Crohn's colitis and the associated changes in fecal microbial profile.
Kao D; Hotte N; Gillevet P; Madsen K
J Clin Gastroenterol; 2014 Aug; 48(7):625-8. PubMed ID: 24667590
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic usefulness of fecal lactoferrin in the assessment of Crohn's disease activity.
Klimczak K; Lykowska-Szuber L; Eder P; Krela-Kazmierczak I; Stawczyk-Eder K; Szymczak A; Michalak M; Studniarek A; Linke K
Eur J Intern Med; 2015 Oct; 26(8):623-7. PubMed ID: 26198785
[TBL] [Abstract][Full Text] [Related]
13. Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn's disease.
Andoh A; Kuzuoka H; Tsujikawa T; Nakamura S; Hirai F; Suzuki Y; Matsui T; Fujiyama Y; Matsumoto T
J Gastroenterol; 2012 Dec; 47(12):1298-307. PubMed ID: 22576027
[TBL] [Abstract][Full Text] [Related]
14. Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota.
Benjamin JL; Hedin CR; Koutsoumpas A; Ng SC; McCarthy NE; Prescott NJ; Pessoa-Lopes P; Mathew CG; Sanderson J; Hart AL; Kamm MA; Knight SC; Forbes A; Stagg AJ; Lindsay JO; Whelan K
Inflamm Bowel Dis; 2012 Jun; 18(6):1092-100. PubMed ID: 22102318
[TBL] [Abstract][Full Text] [Related]
15. Metagenomic Profiling of Fecal-Derived Bacterial Membrane Vesicles in Crohn's Disease Patients.
Kameli N; Becker HEF; Welbers T; Jonkers DMAE; Penders J; Savelkoul P; Stassen FR
Cells; 2021 Oct; 10(10):. PubMed ID: 34685776
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of the gut microbiota of identical twins with Crohn's disease.
Dicksved J; Halfvarson J; Rosenquist M; Järnerot G; Tysk C; Apajalahti J; Engstrand L; Jansson JK
ISME J; 2008 Jul; 2(7):716-27. PubMed ID: 18401439
[TBL] [Abstract][Full Text] [Related]
17. Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease.
Scanlan PD; Shanahan F; O'Mahony C; Marchesi JR
J Clin Microbiol; 2006 Nov; 44(11):3980-8. PubMed ID: 16988018
[TBL] [Abstract][Full Text] [Related]
18. Metagenomic Analysis of Crohn's Disease Patients Identifies Changes in the Virome and Microbiome Related to Disease Status and Therapy, and Detects Potential Interactions and Biomarkers.
Pérez-Brocal V; García-López R; Nos P; Beltrán B; Moret I; Moya A
Inflamm Bowel Dis; 2015 Nov; 21(11):2515-32. PubMed ID: 26313691
[TBL] [Abstract][Full Text] [Related]
19. Crohn's disease in endoscopic remission, obesity, and cases of high genetic risk demonstrates overlapping shifts in the colonic mucosal-luminal interface microbiome.
Jacobs JP; Goudarzi M; Lagishetty V; Li D; Mak T; Tong M; Ruegger P; Haritunians T; Landers C; Fleshner P; Vasiliauskas E; Ippoliti A; Melmed G; Shih D; Targan S; Borneman J; Fornace AJ; McGovern DPB; Braun J
Genome Med; 2022 Aug; 14(1):91. PubMed ID: 35971134
[TBL] [Abstract][Full Text] [Related]
20. Multiple fresh fecal microbiota transplants induces and maintains clinical remission in Crohn's disease complicated with inflammatory mass.
He Z; Li P; Zhu J; Cui B; Xu L; Xiang J; Zhang T; Long C; Huang G; Ji G; Nie Y; Wu K; Fan D; Zhang F
Sci Rep; 2017 Jul; 7(1):4753. PubMed ID: 28684845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
